BFS-Based Prefilled Injectables: Transforming Delivery Systems for Better Outcomes
- Recognize limitations of traditional glass vials as delivery systems for injectables.
- Evaluate the advantages and challenges of prefilled syringes as a preferred delivery system.
- See how Blow-Fill-Seal (BFS) helps fill-finish overcome many of those challenges.
- Identify the challenges of cost and supply constraints and the growing demand for self-administration.
- Analyze lead times for raw materials, fill-finish, and the expensive process of new capacity for prefilled injectables.
- Understand the importance of surge capacity.
- Examine the environmental impact of both glass manufacturing and prefilled injectables.
Reserve a session for your team
What to Expect in this Online Lunch & Learn
We will explore the transformative potential of BFS-based prefilled injectables in improving drug delivery systems and patient outcomes. This session covers several key learning objectives, including the limitations of traditional glass vials as delivery systems for injectables and the advantages and challenges of prefilled syringes as a preferred delivery system. We will highlight how Blow-Fill-Seal (BFS) helps fill-finish overcome many of those challenges, and the challenges of cost and supply constraints along with the growing demand for self-administration. Additionally, we will analyze lead times for raw materials, fill-finish, and the expensive process of new capacity for prefilled injectables, as well as the importance of surge capacity.
Our experts explore the environmental impact of both glass manufacturing and prefilled injectables, providing readers with a comprehensive understanding of the potential benefits and drawbacks of this innovative technology. Participants will have gained a thorough understanding of BFS-based prefilled injectables and their transformative potential in improving drug delivery systems for better patient outcomes.
The Prefilled ApiJect Injector* is the combination of two trusted technologies: BFS aseptic drug packaging process, and a pen needle-style needle hub.
Our approach is just one example of how we are creating prefilled injectors that work for everyone in all markets… that are easy to use, cost effective, and more environmentally friendly.
ApiJect has product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
BFS-Based Prefilled Injectables: Transforming Delivery Systems for Better Outcomes
- Recognize limitations of traditional glass vials as delivery systems for injectables.
- Evaluate the advantages and challenges of prefilled syringes as a preferred delivery system.
- See how Blow-Fill-Seal (BFS) helps fill-finish overcome many of those challenges.
- Identify the challenges of cost and supply constraints and the growing demand for self-administration.
- Analyze lead times for raw materials, fill-finish, and the expensive process of new capacity for prefilled injectables.
- Understand the importance of surge capacity.
- Examine the environmental impact of both glass manufacturing and prefilled injectables.